Spence Asset Management Bio Techne Corp Transaction History

Spence Asset Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 06, 2023	BUY	$73.76 - $85.98 $140,586 - $163,877	1,906 Added 1.71%	113,572 $9.27 Million
Q1 2023 Apr 05, 2023	SELL	$71.62 - $86.62 $35,308 - $42,703	-493 Reduced 0.44%	111,666 $8.28 Million
Q4 2022 Jan 05, 2023	BUY	$80.67 - $352.29 $12,584 - $54,957	156 Added 0.14%	112,159 $9.3 Million
Q4 2022 Jan 05, 2023	BUY	$80.67 - $352.29 $6.78 Million - $29.6 Million	84,072 Added 301.0%	112,003 $9.28 Million
Q3 2022 Oct 04, 2022	SELL	$282.54 - $391.85 $4,238 - $5,877	-15 Reduced 0.05%	27,931 $7.93 Million
Q2 2022 Jul 07, 2022	BUY	$322.67 - $449.65 $66,147 - $92,178	205 Added 0.74%	27,946 $9.69 Million
Q1 2022 Apr 06, 2022	BUY	$353.85 - $487.79 $9.82 Million - $13.5 Million	27,741 New	27,741 $12 Million

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.94B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Spence Asset Management, based on Form 13F filings with the SEC.

Stay updated on Spence Asset Management with notifications on news.